<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>The presence of serum <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> is associated with arterial and <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>We report two cases of portal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> associated with serum <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>In our two patients, <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo>, <z:hpo ids='HP_0011010'>chronic</z:hpo> <z:e sem="disease" ids="C0023895" disease_type="Disease or Syndrome" abbrv="">liver disease</z:e>, <z:hpo ids='HP_0001402'>hepatocellular carcinoma</z:hpo>, <z:hpo ids='HP_0005547'>myeloproliferative disorders</z:hpo> and coagulation inhibitor deficiency were excluded after extensive tests were performed to diagnose portal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> and after a follow-up period of 6 and 7 years, respectively </plain></SENT>
<SENT sid="3" pm="."><plain>The test for serum <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> was positive on two occasions in both patients </plain></SENT>
<SENT sid="4" pm="."><plain>Both patients were treated with endoscopic sclerotherapy for <z:mp ids='MP_0001914'>bleeding</z:mp> <z:hpo ids='HP_0002040'>esophageal varices</z:hpo> and with long term <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> therapy for the prevention of <z:hpo ids='HP_0004419'>recurrent thrombosis</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>These two cases suggest that serum <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> should be investigated in patients with portal vein <z:mp ids='MP_0005048'>thrombosis</z:mp> of unexplained etiology </plain></SENT>
</text></document>